• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Mylan

Mylan

Mylan NV MYL

Last Price$42.06Day Change (%)-1.24%
Open Price$42.69Day Change ($)-0.53
Day Range41.95–42.6952-Week Range37.59–55.50

As of Fri 9/23/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. UPDATE: 5 things we still don't know about EpiPen pricing after Mylan's congressional beating

    UPDATE: 5 things we still don't know about EpiPen pricing after Mylan's congressional beating

  2. Lawmakers rake Mylan CEO Bresch over hot coals over EpiPen price hikes

    Lawmakers rake Mylan CEO Bresch over hot coals over EpiPen price hikes

  3. UPDATE: Lawmakers rake Mylan CEO Bresch over hot coals over EpiPen price hikes

    UPDATE: Lawmakers rake Mylan CEO Bresch over hot coals over EpiPen price hikes

  4. UPDATE: 5 things we still don't know about EpiPen pricing after Mylan's congressional beating

    UPDATE: 5 things we still don't know about EpiPen pricing after Mylan's congressional beating

  5. UPDATE: Things look even worse for Mylan CEO Heather Bresch as she heads to Capitol Hill

    UPDATE: Things look even worse for Mylan CEO Heather Bresch as she heads to Capitol Hill

  6. UPDATE: Things look even worse for Mylan CEO Heather Bresch as she heads to Capitol Hill

    UPDATE: Things look even worse for Mylan CEO Heather Bresch as she heads to Capitol Hill

  7. NY Attorney General's office says Mylan's EpiPen practices may have violated antitrust law

    NY Attorney General's office says Mylan's EpiPen practices may have violated antitrust law

  8. UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

    UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

  9. UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

    UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

  10. UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

    UPDATE: Weekend roundup: Mylan is the perfect target | Tackling high drug prices | The overreaction to the EU and Apple

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.